Tsuyoi Bioscience Technologies Profile
Key Indicators
- Authorised Capital ₹ 10.00 K
- Paid Up Capital ₹ 10.00 K
- Company Age 7 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 48.74%
- Profit Growth 118.97%
- Ebitda 61.99%
- Net Worth 149.18%
- Total Assets 138.05%
About Tsuyoi Bioscience Technologies
Tsuyoi Bioscience Technologies Private Limited (TBTPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 March 2017 (Seven years and 11 months 4 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 K and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Deepak Nishad and Mina Nishad serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2017PTC096080
-
Company No.
096080
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Mar 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Tsuyoi Bioscience Technologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Nishad
|
Director | 06-Mar-2017 | Current |
|
Mina Nishad
|
Director | 06-Mar-2017 | Current |
Financial Performance of Tsuyoi Bioscience Technologies.
Tsuyoi Bioscience Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.74% increase. The company also saw a substantial improvement in profitability, with a 118.97% increase in profit. The company's net worth Soared by an impressive increase of 149.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tsuyoi Bioscience Technologies?
In 2023, Tsuyoi Bioscience Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Tsuyoi Agro Foods Private LimitedDeepak Nishad and Mina Nishad are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tsuyoi Bioscience Technologies?
Unlock and access historical data on people associated with Tsuyoi Bioscience Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tsuyoi Bioscience Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tsuyoi Bioscience Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.